Rank | Gene Set | Z-score |
---|---|---|
1 | * heme biosynthetic process (GO:0006783) | 9.89912558 |
2 | * tetrapyrrole biosynthetic process (GO:0033014) | 9.55059817 |
3 | * porphyrin-containing compound metabolic process (GO:0006778) | 8.90982076 |
4 | oxygen transport (GO:0015671) | 8.34557132 |
5 | * heme metabolic process (GO:0042168) | 8.19334596 |
6 | erythrocyte maturation (GO:0043249) | 7.76222995 |
7 | response to methylmercury (GO:0051597) | 7.64263980 |
8 | gas transport (GO:0015669) | 6.94381303 |
9 | very-low-density lipoprotein particle assembly (GO:0034379) | 6.25758718 |
10 | response to lead ion (GO:0010288) | 6.01408541 |
11 | response to insecticide (GO:0017085) | 5.74194839 |
12 | * tetrapyrrole metabolic process (GO:0033013) | 5.72697748 |
13 | erythrocyte development (GO:0048821) | 5.70815202 |
14 | plasma lipoprotein particle assembly (GO:0034377) | 5.41396500 |
15 | * hemoglobin metabolic process (GO:0020027) | 5.36022518 |
16 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 5.17626403 |
17 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 5.17626403 |
18 | modulation by symbiont of host immune response (GO:0052553) | 5.17626403 |
19 | positive regulation by symbiont of host defense response (GO:0052509) | 5.17626403 |
20 | modulation by symbiont of host defense response (GO:0052031) | 5.17626403 |
21 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 5.17626403 |
22 | cysteine metabolic process (GO:0006534) | 5.06935087 |
23 | heme transport (GO:0015886) | 5.05657461 |
24 | neutrophil activation involved in immune response (GO:0002283) | 4.97879459 |
25 | positive regulation of gamma-delta T cell activation (GO:0046645) | 4.96516059 |
26 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 4.87585691 |
27 | negative regulation of cell killing (GO:0031342) | 4.87585691 |
28 | 3-UTR-mediated mRNA stabilization (GO:0070935) | 4.80514650 |
29 | protein-lipid complex assembly (GO:0065005) | 4.74900387 |
30 | L-phenylalanine catabolic process (GO:0006559) | 4.60910553 |
31 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 4.60910553 |
32 | detection of other organism (GO:0098543) | 4.57457334 |
33 | regulation of B cell receptor signaling pathway (GO:0050855) | 4.49026206 |
34 | positive regulation of fibroblast migration (GO:0010763) | 4.46870080 |
35 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 4.46312121 |
36 | response to arsenic-containing substance (GO:0046685) | 4.46128454 |
37 | negative regulation of fibrinolysis (GO:0051918) | 4.44390357 |
38 | detection of bacterium (GO:0016045) | 4.39737982 |
39 | positive regulation of granulocyte differentiation (GO:0030854) | 4.39145185 |
40 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 4.37531274 |
41 | L-phenylalanine metabolic process (GO:0006558) | 4.37531274 |
42 | microglial cell activation (GO:0001774) | 4.37498515 |
43 | * pigment biosynthetic process (GO:0046148) | 4.35529206 |
44 | aromatic amino acid family catabolic process (GO:0009074) | 4.33684868 |
45 | regulation of platelet aggregation (GO:0090330) | 4.32440674 |
46 | lysine metabolic process (GO:0006553) | 4.29738355 |
47 | lysine catabolic process (GO:0006554) | 4.29738355 |
48 | hepatocyte apoptotic process (GO:0097284) | 4.28639805 |
49 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 4.18667314 |
50 | response to peptidoglycan (GO:0032494) | 4.15600610 |
51 | regulation of protein activation cascade (GO:2000257) | 4.14825449 |
52 | regulation of fibrinolysis (GO:0051917) | 4.13391692 |
53 | glyoxylate metabolic process (GO:0046487) | 4.11959237 |
54 | indole-containing compound catabolic process (GO:0042436) | 4.07887803 |
55 | indolalkylamine catabolic process (GO:0046218) | 4.07887803 |
56 | tryptophan catabolic process (GO:0006569) | 4.07887803 |
57 | kynurenine metabolic process (GO:0070189) | 4.03566918 |
58 | detection of molecule of bacterial origin (GO:0032490) | 4.00557821 |
59 | detection of external biotic stimulus (GO:0098581) | 3.98806966 |
60 | regulation of response to osmotic stress (GO:0047484) | 3.98119760 |
61 | macrophage activation involved in immune response (GO:0002281) | 3.95820280 |
62 | high-density lipoprotein particle remodeling (GO:0034375) | 3.95301884 |
63 | * pigment metabolic process (GO:0042440) | 3.95020094 |
64 | plasma lipoprotein particle organization (GO:0071827) | 3.92115691 |
65 | regulation of complement activation (GO:0030449) | 3.91694748 |
66 | modulation by virus of host process (GO:0019054) | 3.90499759 |
67 | complement activation, alternative pathway (GO:0006957) | 3.83463752 |
68 | leukocyte aggregation (GO:0070486) | 3.80908459 |
69 | tryptophan metabolic process (GO:0006568) | 3.80658744 |
70 | regulation of necroptotic process (GO:0060544) | 3.77757139 |
71 | regulation of cytokine secretion involved in immune response (GO:0002739) | 3.76631863 |
72 | viral protein processing (GO:0019082) | 3.74314038 |
73 | negative regulation of cAMP-mediated signaling (GO:0043951) | 3.72966163 |
74 | iron ion import (GO:0097286) | 3.72931813 |
75 | bile acid biosynthetic process (GO:0006699) | 3.72431474 |
76 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 3.72276371 |
77 | neutrophil mediated immunity (GO:0002446) | 3.70833974 |
78 | negative regulation of necroptotic process (GO:0060546) | 3.69971565 |
79 | regulation of triglyceride catabolic process (GO:0010896) | 3.69021476 |
80 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 3.67409462 |
81 | alpha-linolenic acid metabolic process (GO:0036109) | 3.65817590 |
82 | reverse cholesterol transport (GO:0043691) | 3.64968830 |
83 | neutrophil activation (GO:0042119) | 3.63504102 |
84 | cellular response to virus (GO:0098586) | 3.63419237 |
85 | protein-lipid complex subunit organization (GO:0071825) | 3.63136065 |
86 | * erythrocyte differentiation (GO:0030218) | 3.62594249 |
87 | negative regulation of interleukin-12 production (GO:0032695) | 3.62231268 |
88 | respiratory burst (GO:0045730) | 3.61773415 |
89 | negative regulation of execution phase of apoptosis (GO:1900118) | 3.61357034 |
90 | myeloid cell development (GO:0061515) | 3.60709757 |
91 | peptidyl-glutamic acid carboxylation (GO:0017187) | 3.57614848 |
92 | protein carboxylation (GO:0018214) | 3.57614848 |
93 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 3.57610829 |
94 | response to host immune response (GO:0052572) | 3.57610829 |
95 | cellular extravasation (GO:0045123) | 3.57049632 |
96 | plasma lipoprotein particle clearance (GO:0034381) | 3.55219236 |
97 | * cofactor biosynthetic process (GO:0051188) | 3.55102375 |
98 | GDP-mannose metabolic process (GO:0019673) | 3.53818508 |
99 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 3.53486951 |
100 | cofactor catabolic process (GO:0051187) | 3.53293363 |
101 | phospholipid efflux (GO:0033700) | 3.52172287 |
102 | water-soluble vitamin biosynthetic process (GO:0042364) | 3.52080022 |
103 | antigen processing and presentation of endogenous antigen (GO:0019883) | 3.51823100 |
104 | urea cycle (GO:0000050) | 3.51626080 |
105 | urea metabolic process (GO:0019627) | 3.51626080 |
106 | modulation by symbiont of host cellular process (GO:0044068) | 3.50010979 |
107 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 3.49098254 |
108 | one-carbon compound transport (GO:0019755) | 3.47493711 |
109 | macrophage activation (GO:0042116) | 3.45283633 |
110 | amino-acid betaine metabolic process (GO:0006577) | 3.45270566 |
111 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 3.42924091 |
112 | regulation of gamma-delta T cell activation (GO:0046643) | 3.42303455 |
113 | regulation of interferon-beta biosynthetic process (GO:0045357) | 3.41111998 |
114 | detection of biotic stimulus (GO:0009595) | 3.40151408 |
115 | blood coagulation, intrinsic pathway (GO:0007597) | 3.37930559 |
116 | leukocyte migration involved in inflammatory response (GO:0002523) | 3.37867424 |
117 | response to dexamethasone (GO:0071548) | 3.37672522 |
118 | cholesterol efflux (GO:0033344) | 3.36848706 |
119 | plasma lipoprotein particle remodeling (GO:0034369) | 3.35656199 |
120 | protein-lipid complex remodeling (GO:0034368) | 3.35656199 |
121 | macromolecular complex remodeling (GO:0034367) | 3.35656199 |
122 | granulocyte activation (GO:0036230) | 3.34150219 |
123 | nitrogen cycle metabolic process (GO:0071941) | 3.31688218 |
124 | bicarbonate transport (GO:0015701) | 3.31176265 |
125 | negative regulation of glial cell proliferation (GO:0060253) | 3.30768112 |
126 | regulation of mast cell degranulation (GO:0043304) | 3.28372754 |
127 | glycine metabolic process (GO:0006544) | 3.27639203 |
128 | sulfur amino acid catabolic process (GO:0000098) | 3.27427080 |
129 | iron coordination entity transport (GO:1901678) | 3.27314650 |
130 | L-alpha-amino acid transmembrane transport (GO:1902475) | 3.27211925 |
131 | negative regulation of erythrocyte differentiation (GO:0045647) | 3.26781217 |
132 | cellular response to dexamethasone stimulus (GO:0071549) | 3.26568921 |
133 | negative regulation of amyloid precursor protein catabolic process (GO:1902992) | 3.26181061 |
134 | pyridine-containing compound biosynthetic process (GO:0072525) | 3.26016268 |
135 | serine family amino acid metabolic process (GO:0009069) | 3.25922902 |
136 | serine family amino acid catabolic process (GO:0009071) | 3.25381856 |
137 | negative regulation of viral entry into host cell (GO:0046597) | 3.24305918 |
138 | response to host (GO:0075136) | 3.24275311 |
139 | response to host defenses (GO:0052200) | 3.24275311 |
140 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 3.24275311 |
141 | homocysteine metabolic process (GO:0050667) | 3.22714621 |
142 | ethanol oxidation (GO:0006069) | 3.22642146 |
143 | positive regulation of insulin receptor signaling pathway (GO:0046628) | 3.22102212 |
144 | response to interleukin-15 (GO:0070672) | 3.19476428 |
145 | positive regulation of lipoprotein lipase activity (GO:0051006) | 3.17604952 |
146 | positive regulation of triglyceride lipase activity (GO:0061365) | 3.17604952 |
147 | regulation of granulocyte differentiation (GO:0030852) | 3.16971849 |
148 | triglyceride homeostasis (GO:0070328) | 3.16934857 |
149 | acylglycerol homeostasis (GO:0055090) | 3.16934857 |
150 | myeloid leukocyte mediated immunity (GO:0002444) | 3.16862794 |
151 | negative regulation of phagocytosis (GO:0050765) | 3.16730274 |
152 | myeloid cell activation involved in immune response (GO:0002275) | 3.15543936 |
153 | response to nitrosative stress (GO:0051409) | 3.14889777 |
154 | negative regulation of T cell mediated immunity (GO:0002710) | 3.11198348 |
155 | arginine metabolic process (GO:0006525) | 3.10482749 |
156 | regulation of cholesterol esterification (GO:0010872) | 3.09112826 |
157 | glutamate metabolic process (GO:0006536) | 3.07961308 |
158 | positive regulation of tumor necrosis factor biosynthetic process (GO:0042535) | 3.05012972 |
159 | cellular hyperosmotic response (GO:0071474) | 3.04951602 |
160 | negative regulation of protein activation cascade (GO:2000258) | 3.04609123 |
161 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 3.04248837 |
162 | negative regulation of leukocyte mediated immunity (GO:0002704) | 3.01303991 |
163 | regulation of mast cell activation involved in immune response (GO:0033006) | 3.00538772 |
164 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 2.99994874 |
165 | bile acid metabolic process (GO:0008206) | 2.99613568 |
166 | regulation of gamma-delta T cell differentiation (GO:0045586) | 2.99232156 |
167 | positive thymic T cell selection (GO:0045059) | 2.98100441 |
168 | aromatic amino acid family metabolic process (GO:0009072) | 2.97396692 |
169 | positive regulation of mast cell activation (GO:0033005) | 2.96297707 |
170 | fibrinolysis (GO:0042730) | 2.96103139 |
171 | mitochondrion degradation (GO:0000422) | 2.94755814 |
172 | alpha-amino acid catabolic process (GO:1901606) | 2.93324151 |
173 | leukocyte degranulation (GO:0043299) | 2.91457627 |
174 | amine catabolic process (GO:0009310) | 2.91349161 |
175 | cellular biogenic amine catabolic process (GO:0042402) | 2.91349161 |
176 | carnitine metabolic process (GO:0009437) | 2.91135675 |
177 | negative regulation of necrotic cell death (GO:0060547) | 2.90109100 |
178 | negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515) | 2.88129482 |
179 | nucleotide-binding domain, leucine rich repeat containing receptor signaling pathway (GO:0035872) | 2.87736554 |
180 | B cell receptor signaling pathway (GO:0050853) | 2.82332594 |
181 | cellular response to interleukin-15 (GO:0071350) | 2.81335613 |
182 | regulation of mast cell activation (GO:0033003) | 2.79803056 |
183 | production of molecular mediator involved in inflammatory response (GO:0002532) | 2.78356465 |
184 | regulation of leukocyte degranulation (GO:0043300) | 2.78196849 |
185 | megakaryocyte development (GO:0035855) | 2.75849565 |
186 | * protoporphyrinogen IX metabolic process (GO:0046501) | 16.5652768 |
187 | * protoporphyrinogen IX biosynthetic process (GO:0006782) | 14.3076290 |
188 | * porphyrin-containing compound biosynthetic process (GO:0006779) | 10.7140319 |
Rank | Gene Set | Z-score |
---|---|---|
1 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 6.96819002 |
2 | GATA1_22025678_ChIP-Seq_K562_Human | 6.10257622 |
3 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 5.62962242 |
4 | E2F7_22180533_ChIP-Seq_HELA_Human | 5.16647455 |
5 | * EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 4.96413404 |
6 | GATA1_19941826_ChIP-Seq_K562_Human | 4.61344395 |
7 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 4.60458187 |
8 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 4.43343380 |
9 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 4.41149376 |
10 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 4.02408085 |
11 | * TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 3.72351740 |
12 | * GATA1_19941827_ChIP-Seq_MEL_Mouse | 3.52052895 |
13 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 3.49537455 |
14 | * KLF1_20508144_ChIP-Seq_FETAL-LIVER-ERYTHROID_Mouse | 3.48419407 |
15 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 3.34488041 |
16 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 3.15250784 |
17 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 2.99171911 |
18 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.92734979 |
19 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 2.87883942 |
20 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.73006851 |
21 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 2.71313850 |
22 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 2.61181616 |
23 | * GATA2_19941826_ChIP-Seq_K562_Human | 2.60713395 |
24 | SCL_19346495_ChIP-Seq_HPC-7_Human | 2.54094127 |
25 | SPI1_23547873_ChIP-Seq_NB4_Human | 2.49626116 |
26 | VDR_24763502_ChIP-Seq_THP-1_Human | 2.49080559 |
27 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 2.46095029 |
28 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 2.36347778 |
29 | SPI1_23127762_ChIP-Seq_K562_Human | 2.36164665 |
30 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 2.35119494 |
31 | * GATA1_22383799_ChIP-Seq_G1ME_Mouse | 2.20548249 |
32 | RUNX_20019798_ChIP-Seq_JUKART_Human | 2.19484856 |
33 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 2.19307889 |
34 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 2.17838872 |
35 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 2.14234693 |
36 | MYB_26560356_Chip-Seq_TH2_Human | 2.11884560 |
37 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 2.10977488 |
38 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 2.10441405 |
39 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 2.07791058 |
40 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 2.07404020 |
41 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 2.05571375 |
42 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.99300995 |
43 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.99281856 |
44 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.97853067 |
45 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.95525049 |
46 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 1.92803375 |
47 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.92427290 |
48 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.92277353 |
49 | MYB_26560356_Chip-Seq_TH1_Human | 1.91595982 |
50 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 1.88579830 |
51 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.83770570 |
52 | MAF_26560356_Chip-Seq_TH2_Human | 1.73384312 |
53 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.69820060 |
54 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.59300939 |
55 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.58004708 |
56 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.52007993 |
57 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 1.50549459 |
58 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.49866668 |
59 | CHD7_19251738_ChIP-ChIP_MESCs_Mouse | 1.43419971 |
60 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.43345604 |
61 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.40040483 |
62 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.39158505 |
63 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.34470923 |
64 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 1.32925446 |
65 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.31135578 |
66 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.27383624 |
67 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.26353811 |
68 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.26046823 |
69 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.25872154 |
70 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.25063767 |
71 | AR_21909140_ChIP-Seq_LNCAP_Human | 1.24388582 |
72 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.23908490 |
73 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.22906901 |
74 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.21019802 |
75 | NCOR1_26117541_ChIP-Seq_K562_Human | 1.20338152 |
76 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.19291082 |
77 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.17856101 |
78 | * GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.17556836 |
79 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.16151626 |
80 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.16028194 |
81 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.14620185 |
82 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.13310035 |
83 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.12534307 |
84 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.11996810 |
85 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.11955961 |
86 | * EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 1.11032893 |
87 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.10023839 |
88 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.05552394 |
89 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.05298124 |
90 | E2F1_21310950_ChIP-Seq_MCF-7_Human | 1.05093912 |
91 | KDM2B_26808549_Chip-Seq_K562_Human | 1.04569738 |
92 | CUX1_19635798_ChIP-ChIP_MULTIPLE_HUMAN_CANCER_TYPES_Human | 1.04357479 |
93 | SMAD1_18555785_ChIP-Seq_MESCs_Mouse | 1.03629917 |
94 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.02312653 |
95 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.01862454 |
96 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.98452105 |
97 | RUNX1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.97785379 |
98 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 0.96538162 |
99 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 0.96333473 |
100 | MYC_22102868_ChIP-Seq_BL_Human | 0.95441826 |
101 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.95284174 |
102 | VDR_21846776_ChIP-Seq_THP-1_Human | 0.94571071 |
103 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 0.94406363 |
104 | GATA3_26560356_Chip-Seq_TH2_Human | 0.93259230 |
105 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 0.92608943 |
106 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 0.89251196 |
107 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 0.86078539 |
108 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 0.85044781 |
109 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 0.84516395 |
110 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.83216221 |
111 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.82974950 |
112 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 0.81159086 |
113 | HSF1_23293686_ChIP-Seq_STHDH_STRIATAL_Mouse | 0.80086259 |
114 | MAF_26560356_Chip-Seq_TH1_Human | 0.79636373 |
115 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 0.75696405 |
116 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 0.74220379 |
117 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 0.74145814 |
118 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 0.73472768 |
119 | GATA1_19941827_ChIP-Seq_MEL86_Mouse | 0.73452558 |
120 | MYBL2_22936984_ChIP-ChIP_MESCs_Mouse | 0.73370392 |
121 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 0.73201792 |
122 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 0.71625277 |
123 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.71134713 |
124 | HOXD13_18407260_ChIP-ChIP_DEVELOPING-LIMBS_Mouse | 0.71090277 |
125 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.70301247 |
126 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 0.70294779 |
127 | HNF4A_19822575_ChIP-Seq_HepG2_Human | 0.70238558 |
128 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 0.69497513 |
129 | GATA6_25053715_ChIP-Seq_YYC3_Human | 0.68886312 |
130 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 0.68529152 |
131 | NELFA_20434984_ChIP-Seq_ESCs_Mouse | 0.67127622 |
132 | UTX_26944678_Chip-Seq_JUKART_Human | 0.66679907 |
133 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 0.66019377 |
134 | CCND1_20090754_ChIP-ChIP_RETINA_Mouse | 0.65385880 |
135 | KDM2B_26808549_Chip-Seq_DND41_Human | 0.63593403 |
136 | SOX2_16153702_ChIP-ChIP_HESCs_Human | 0.63424882 |
137 | SPI1_20517297_ChIP-Seq_HL60_Human | 0.62761779 |
138 | * ELF1_20517297_ChIP-Seq_JURKAT_Human | 0.62740844 |
139 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 0.62639813 |
140 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 0.61433006 |
141 | SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 0.60796161 |
142 | ETS1_22383799_ChIP-Seq_G1ME_Mouse | 0.59660669 |
143 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.59638733 |
144 | CTCF_21964334_Chip-Seq_Bcells_Human | 0.59438568 |
145 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 0.58544923 |
146 | SALL4_22934838_ChIP-ChIP_CD34+_Human | 0.57860671 |
147 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 0.57622138 |
148 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 0.57490330 |
149 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.57424239 |
150 | TCF7_22412390_ChIP-Seq_EML_Mouse | 0.57191614 |
151 | KDM5A_27292631_Chip-Seq_BREAST_Human | 0.55867264 |
152 | * RUNX1_22412390_ChIP-Seq_EML_Mouse | 0.54895468 |
153 | FOXP2_23625967_ChIP-Seq_PFSK-1_AND_SK-N-MC_Human | 0.54562254 |
154 | GATA3_20176728_ChIP-ChIP_TSCs_Mouse | 0.54233681 |
155 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 0.53637981 |
156 | BCL3_23251550_ChIP-Seq_MUSCLE_Mouse | 0.53577877 |
157 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 0.53554716 |
158 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.53330417 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MP0004147_increased_porphyrin_level | 8.98265995 |
2 | MP0002139_abnormal_hepatobiliary_system | 5.27978043 |
3 | MP0005360_urolithiasis | 4.48227458 |
4 | MP0005083_abnormal_biliary_tract | 4.06914257 |
5 | MP0005085_abnormal_gallbladder_physiolo | 4.05294446 |
6 | MP0003724_increased_susceptibility_to | 3.70397610 |
7 | MP0003436_decreased_susceptibility_to | 3.37608475 |
8 | MP0005365_abnormal_bile_salt | 3.30725652 |
9 | MP0003806_abnormal_nucleotide_metabolis | 2.69983670 |
10 | MP0002419_abnormal_innate_immunity | 2.60195333 |
11 | MP0001835_abnormal_antigen_presentation | 2.59531792 |
12 | MP0008875_abnormal_xenobiotic_pharmacok | 2.53531261 |
13 | MP0005025_abnormal_response_to | 2.48680861 |
14 | MP0009785_altered_susceptibility_to | 2.41138935 |
15 | MP0010329_abnormal_lipoprotein_level | 2.26703219 |
16 | MP0003252_abnormal_bile_duct | 2.19925549 |
17 | MP0001800_abnormal_humoral_immune | 2.19016677 |
18 | MP0001790_abnormal_immune_system | 2.17774320 |
19 | MP0005387_immune_system_phenotype | 2.17774320 |
20 | MP0005671_abnormal_response_to | 2.15788359 |
21 | MP0002420_abnormal_adaptive_immunity | 2.13341100 |
22 | MP0003172_abnormal_lysosome_physiology | 2.10214133 |
23 | MP0001819_abnormal_immune_cell | 2.10158117 |
24 | MP0005000_abnormal_immune_tolerance | 2.08864459 |
25 | MP0002405_respiratory_system_inflammati | 2.01234781 |
26 | MP0006082_CNS_inflammation | 2.01214480 |
27 | MP0003656_abnormal_erythrocyte_physiolo | 10.1319825 |
28 | MP0002723_abnormal_immune_serum | 1.96127121 |
29 | MP0003866_abnormal_defecation | 1.94974670 |
30 | MP0002452_abnormal_antigen_presenting | 1.86410306 |
31 | MP0009840_abnormal_foam_cell | 1.85748348 |
32 | MP0002138_abnormal_hepatobiliary_system | 1.85288137 |
33 | MP0003878_abnormal_ear_physiology | 1.84219081 |
34 | MP0005377_hearing/vestibular/ear_phenot | 1.84219081 |
35 | MP0003763_abnormal_thymus_physiology | 1.82992041 |
36 | MP0009278_abnormal_bone_marrow | 1.80868186 |
37 | MP0000609_abnormal_liver_physiology | 1.80749440 |
38 | MP0003191_abnormal_cellular_cholesterol | 1.79179431 |
39 | MP0005075_abnormal_melanosome_morpholog | 1.78875767 |
40 | * MP0005636_abnormal_mineral_homeostasis | 1.77908516 |
41 | MP0003111_abnormal_nucleus_morphology | 1.77337783 |
42 | MP0000716_abnormal_immune_system | 1.64928784 |
43 | MP0010155_abnormal_intestine_physiology | 1.57936111 |
44 | MP0003186_abnormal_redox_activity | 1.57429873 |
45 | MP0004381_abnormal_hair_follicle | 1.57302564 |
46 | MP0006036_abnormal_mitochondrial_physio | 1.56393038 |
47 | MP0001666_abnormal_nutrient_absorption | 1.55357676 |
48 | MP0000015_abnormal_ear_pigmentation | 1.54246522 |
49 | MP0002148_abnormal_hypersensitivity_rea | 1.47960688 |
50 | MP0005451_abnormal_body_composition | 1.47936831 |
51 | MP0001533_abnormal_skeleton_physiology | 1.44241549 |
52 | MP0005397_hematopoietic_system_phenotyp | 1.43582204 |
53 | MP0001545_abnormal_hematopoietic_system | 1.43582204 |
54 | MP0004947_skin_inflammation | 1.43380170 |
55 | MP0000703_abnormal_thymus_morphology | 1.41049956 |
56 | MP0001845_abnormal_inflammatory_respons | 1.40625614 |
57 | MP0009333_abnormal_splenocyte_physiolog | 1.40234671 |
58 | MP0005332_abnormal_amino_acid | 1.36776379 |
59 | MP0005319_abnormal_enzyme/_coenzyme | 1.36564208 |
60 | MP0005464_abnormal_platelet_physiology | 1.29296702 |
61 | MP0005310_abnormal_salivary_gland | 1.27497694 |
62 | MP0002118_abnormal_lipid_homeostasis | 1.27186127 |
63 | MP0003828_pulmonary_edema | 1.25377395 |
64 | MP0003705_abnormal_hypodermis_morpholog | 1.23416248 |
65 | MP0001764_abnormal_homeostasis | 1.18660837 |
66 | MP0010368_abnormal_lymphatic_system | 1.16414665 |
67 | MP0008775_abnormal_heart_ventricle | 1.14127081 |
68 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.12559258 |
69 | MP0000598_abnormal_liver_morphology | 1.12513419 |
70 | MP0000858_altered_metastatic_potential | 1.09930449 |
71 | MP0003195_calcinosis | 1.09858332 |
72 | MP0009764_decreased_sensitivity_to | 1.08675855 |
73 | MP0003183_abnormal_peptide_metabolism | 1.08159712 |
74 | MP0004883_abnormal_blood_vessel | 1.07948804 |
75 | MP0000490_abnormal_crypts_of | 1.07846272 |
76 | MP0009643_abnormal_urine_homeostasis | 1.07494011 |
77 | MP0001851_eye_inflammation | 1.07065985 |
78 | MP0000465_gastrointestinal_hemorrhage | 1.05674307 |
79 | MP0005501_abnormal_skin_physiology | 1.05341256 |
80 | MP0001663_abnormal_digestive_system | 1.04964864 |
81 | MP0003868_abnormal_feces_composition | 1.00314009 |
82 | MP0005174_abnormal_tail_pigmentation | 0.99924065 |
83 | MP0002277_abnormal_respiratory_mucosa | 0.98422430 |
84 | MP0009763_increased_sensitivity_to | 0.97600889 |
85 | MP0004808_abnormal_hematopoietic_stem | 0.95185244 |
86 | MP0010307_abnormal_tumor_latency | 0.93746921 |
87 | MP0009765_abnormal_xenobiotic_induced | 0.93222225 |
88 | MP0009053_abnormal_anal_canal | 0.92062028 |
89 | MP0002166_altered_tumor_susceptibility | 0.91802150 |
90 | MP0008872_abnormal_physiological_respon | 0.91032720 |
91 | MP0003077_abnormal_cell_cycle | 0.89180169 |
92 | MP0010094_abnormal_chromosome_stability | 0.88183708 |
93 | MP0003453_abnormal_keratinocyte_physiol | 0.85091634 |
94 | MP0005164_abnormal_response_to | 0.83215494 |
95 | MP0009697_abnormal_copulation | 0.82993661 |
96 | MP0002653_abnormal_ependyma_morphology | 0.82281264 |
97 | MP0002132_abnormal_respiratory_system | 0.81916222 |
98 | MP0001873_stomach_inflammation | 0.79718886 |
99 | MP0008260_abnormal_autophagy | 0.79103471 |
100 | MP0004019_abnormal_vitamin_homeostasis | 0.78970047 |
101 | MP0003011_delayed_dark_adaptation | 0.74388034 |
102 | * MP0009931_abnormal_skin_appearance | 0.73783763 |
103 | MP0000689_abnormal_spleen_morphology | 0.73435714 |
104 | MP0002837_dystrophic_cardiac_calcinosis | 0.71672869 |
105 | MP0003045_fibrosis | 0.71227859 |
106 | MP0000749_muscle_degeneration | 0.69935035 |
107 | MP0002398_abnormal_bone_marrow | 0.69679595 |
108 | MP0008874_decreased_physiological_sensi | 0.69294677 |
109 | MP0004130_abnormal_muscle_cell | 0.68906988 |
110 | MP0004510_myositis | 0.68784477 |
111 | MP0003300_gastrointestinal_ulcer | 0.68494584 |
112 | MP0002722_abnormal_immune_system | 0.66938224 |
113 | MP0003690_abnormal_glial_cell | 0.66830776 |
114 | MP0008004_abnormal_stomach_pH | 0.66011078 |
115 | MP0008469_abnormal_protein_level | 0.66002847 |
116 | MP0005376_homeostasis/metabolism_phenot | 0.65743150 |
117 | MP0000685_abnormal_immune_system | 0.64623931 |
118 | MP0000343_altered_response_to | 0.63606346 |
119 | MP0005076_abnormal_cell_differentiation | 0.63592350 |
120 | MP0002332_abnormal_exercise_endurance | 0.62878700 |
121 | MP0008770_decreased_survivor_rate | 0.61314284 |
122 | MP0002998_abnormal_bone_remodeling | 0.60048247 |
123 | MP0005647_abnormal_sex_gland | 0.59931482 |
124 | MP0009642_abnormal_blood_homeostasis | 0.58988798 |
125 | MP0002095_abnormal_skin_pigmentation | 0.58960702 |
126 | MP0005381_digestive/alimentary_phenotyp | 0.57792340 |
127 | MP0003943_abnormal_hepatobiliary_system | 0.57036167 |
128 | MP0001756_abnormal_urination | 0.56684223 |
129 | MP0008995_early_reproductive_senescence | 0.56095136 |
130 | * MP0002429_abnormal_blood_cell | 0.56093933 |
131 | MP0005166_decreased_susceptibility_to | 0.55981569 |
132 | MP0000371_diluted_coat_color | 0.55617786 |
133 | MP0005266_abnormal_metabolism | 0.53434527 |
134 | MP0004264_abnormal_extraembryonic_tissu | 0.52626080 |
135 | MP0005334_abnormal_fat_pad | 0.52008472 |
136 | MP0002877_abnormal_melanocyte_morpholog | 0.51402046 |
137 | MP0009672_abnormal_birth_weight | 0.49384811 |
138 | MP0002019_abnormal_tumor_incidence | 0.49066706 |
139 | MP0002396_abnormal_hematopoietic_system | 0.47742848 |
140 | MP0002971_abnormal_brown_adipose | 0.47715159 |
141 | MP0002078_abnormal_glucose_homeostasis | 0.47710882 |
142 | MP0005535_abnormal_body_temperature | 0.47105077 |
143 | MP0002136_abnormal_kidney_physiology | 0.45645471 |
144 | MP0001544_abnormal_cardiovascular_syste | 0.44288071 |
145 | MP0005385_cardiovascular_system_phenoty | 0.44288071 |
146 | MP0006035_abnormal_mitochondrial_morpho | 0.44172223 |
147 | MP0010771_integument_phenotype | 0.42556222 |
148 | MP0003303_peritoneal_inflammation | 0.42202126 |
149 | MP0008873_increased_physiological_sensi | 0.41929616 |
150 | MP0003221_abnormal_cardiomyocyte_apopto | 0.41883705 |
151 | MP0000604_amyloidosis | 0.41291935 |
152 | MP0002970_abnormal_white_adipose | 0.40941599 |
153 | MP0004215_abnormal_myocardial_fiber | 0.40010046 |
154 | MP0000350_abnormal_cell_proliferation | 0.39731208 |
155 | MP0001191_abnormal_skin_condition | 0.38442670 |
156 | MP0002972_abnormal_cardiac_muscle | 0.37949262 |
157 | MP0000313_abnormal_cell_death | 0.37648447 |
158 | MP0004185_abnormal_adipocyte_glucose | 0.37609707 |
159 | * MP0002086_abnormal_extraembryonic_tissu | 0.36149959 |
160 | MP0001730_embryonic_growth_arrest | 0.35514057 |
161 | MP0001243_abnormal_dermal_layer | 0.34913463 |
162 | MP0003693_abnormal_embryo_hatching | 0.34694912 |
163 | MP0002135_abnormal_kidney_morphology | 0.33425730 |
164 | MP0004197_abnormal_fetal_growth/weight/ | 0.32407054 |
165 | MP0003075_altered_response_to | 0.32230238 |
166 | MP0004085_abnormal_heartbeat | 0.32201974 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Acanthocytosis (HP:0001927) | 9.31794833 |
2 | Reticulocytosis (HP:0001923) | 7.67023072 |
3 | * Cholelithiasis (HP:0001081) | 6.26791299 |
4 | Hyperbilirubinemia (HP:0002904) | 6.20673700 |
5 | Diaphragmatic weakness (HP:0009113) | 5.84803663 |
6 | * Abnormal gallbladder morphology (HP:0012437) | 5.78170744 |
7 | Paralysis (HP:0003470) | 5.67841634 |
8 | Eczematoid dermatitis (HP:0000976) | 5.62619435 |
9 | Abnormal gallbladder physiology (HP:0012438) | 5.38747553 |
10 | Cholecystitis (HP:0001082) | 5.38747553 |
11 | Recurrent abscess formation (HP:0002722) | 5.31792613 |
12 | Recurrent bacterial skin infections (HP:0005406) | 5.26088125 |
13 | * Hypochromic anemia (HP:0001931) | 5.08433750 |
14 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 5.04431796 |
15 | Abnormality of reticulocytes (HP:0004312) | 4.85103022 |
16 | Abnormal hemoglobin (HP:0011902) | 4.83925759 |
17 | Deep venous thrombosis (HP:0002625) | 4.71015508 |
18 | Myositis (HP:0100614) | 4.52974603 |
19 | Abnormality of macrophages (HP:0004311) | 4.45066104 |
20 | Hepatocellular carcinoma (HP:0001402) | 4.44603468 |
21 | Osteomalacia (HP:0002749) | 4.37793763 |
22 | Polycythemia (HP:0001901) | 4.35385067 |
23 | Stomatitis (HP:0010280) | 4.26734240 |
24 | Intrahepatic cholestasis (HP:0001406) | 4.22183172 |
25 | Gastrointestinal infarctions (HP:0005244) | 4.20584581 |
26 | Ileus (HP:0002595) | 4.18609771 |
27 | * Abnormality of the gallbladder (HP:0005264) | 4.13302101 |
28 | Orchitis (HP:0100796) | 4.12701349 |
29 | Insomnia (HP:0100785) | 4.05506312 |
30 | Retrobulbar optic neuritis (HP:0100654) | 3.81560572 |
31 | Optic neuritis (HP:0100653) | 3.81560572 |
32 | Xanthomatosis (HP:0000991) | 3.73511083 |
33 | Obstructive lung disease (HP:0006536) | 3.66112240 |
34 | Chronic obstructive pulmonary disease (HP:0006510) | 3.66112240 |
35 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 3.64611371 |
36 | Slow saccadic eye movements (HP:0000514) | 3.63003533 |
37 | Prolonged partial thromboplastin time (HP:0003645) | 3.62103454 |
38 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 3.61432207 |
39 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 3.60346965 |
40 | Complement deficiency (HP:0004431) | 3.60248843 |
41 | Elevated erythrocyte sedimentation rate (HP:0003565) | 3.58556956 |
42 | Hypobetalipoproteinemia (HP:0003563) | 3.40700830 |
43 | Recurrent fungal infections (HP:0002841) | 3.34523764 |
44 | Recurrent skin infections (HP:0001581) | 3.33467765 |
45 | * Urticaria (HP:0001025) | 3.30443458 |
46 | Spontaneous hematomas (HP:0007420) | 3.25841705 |
47 | * Microcytic anemia (HP:0001935) | 3.18572117 |
48 | Gingivitis (HP:0000230) | 3.16363580 |
49 | Nausea (HP:0002018) | 3.15142123 |
50 | Meningitis (HP:0001287) | 3.11911840 |
51 | Encephalitis (HP:0002383) | 3.09481938 |
52 | Keratoconjunctivitis sicca (HP:0001097) | 3.08826951 |
53 | Inflammation of the large intestine (HP:0002037) | 3.02211337 |
54 | Mediastinal lymphadenopathy (HP:0100721) | 2.98125945 |
55 | Joint hemorrhage (HP:0005261) | 2.93981509 |
56 | Hypolipoproteinemia (HP:0010981) | 2.91750160 |
57 | * Cutaneous photosensitivity (HP:0000992) | 2.89543940 |
58 | Toxemia of pregnancy (HP:0100603) | 2.89447250 |
59 | Gastrointestinal inflammation (HP:0004386) | 2.89282546 |
60 | Abnormality of iron homeostasis (HP:0011031) | 2.89017729 |
61 | Hyperlipoproteinemia (HP:0010980) | 2.88552625 |
62 | Cellulitis (HP:0100658) | 2.86489741 |
63 | Increased serum ferritin (HP:0003281) | 2.84327073 |
64 | Keratoconjunctivitis (HP:0001096) | 2.84038790 |
65 | Hypoalphalipoproteinemia (HP:0003233) | 2.83669797 |
66 | Episodic fever (HP:0001954) | 2.82795607 |
67 | Vasculitis (HP:0002633) | 2.81422375 |
68 | Abnormality of the common coagulation pathway (HP:0010990) | 2.79102511 |
69 | Cerebral palsy (HP:0100021) | 2.76772225 |
70 | Increased IgE level (HP:0003212) | 2.75550982 |
71 | Anorexia (HP:0002039) | 2.72298470 |
72 | Abnormality of complement system (HP:0005339) | 2.71421001 |
73 | Chronic mucocutaneous candidiasis (HP:0002728) | 2.69893956 |
74 | Recurrent cutaneous fungal infections (HP:0011370) | 2.69893956 |
75 | Hematochezia (HP:0002573) | 2.66680144 |
76 | Abnormality of transition element cation homeostasis (HP:0011030) | 2.66511006 |
77 | Confusion (HP:0001289) | 2.62464001 |
78 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 2.62130823 |
79 | Hypoglycemic coma (HP:0001325) | 2.61356613 |
80 | T lymphocytopenia (HP:0005403) | 2.61160644 |
81 | Metabolic acidosis (HP:0001942) | 2.56718048 |
82 | Peritonitis (HP:0002586) | 2.56345158 |
83 | Postural instability (HP:0002172) | 2.55605111 |
84 | Abnormality of T cell number (HP:0011839) | 2.55338738 |
85 | Osteomyelitis (HP:0002754) | 2.50763353 |
86 | Hyperammonemia (HP:0001987) | 2.47384128 |
87 | Visual hallucinations (HP:0002367) | 2.47110153 |
88 | Chest pain (HP:0100749) | 2.46264004 |
89 | Leukocytosis (HP:0001974) | 2.45894618 |
90 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 2.45282333 |
91 | Increased IgM level (HP:0003496) | 2.40707094 |
92 | Recurrent viral infections (HP:0004429) | 2.40187786 |
93 | Abnormality of T cells (HP:0002843) | 2.34520035 |
94 | Global brain atrophy (HP:0002283) | 2.34001808 |
95 | Ketosis (HP:0001946) | 2.31741144 |
96 | Hyponatremia (HP:0002902) | 2.28517646 |
97 | Arterial thrombosis (HP:0004420) | 2.25257891 |
98 | Rickets (HP:0002748) | 2.25196060 |
99 | Nonimmune hydrops fetalis (HP:0001790) | 2.21994652 |
100 | Hemorrhage of the eye (HP:0011885) | 2.21704008 |
101 | Epidermoid cyst (HP:0200040) | 2.21683795 |
102 | Hypertriglyceridemia (HP:0002155) | 2.21217080 |
103 | Pulmonary infiltrates (HP:0002113) | 2.19880420 |
104 | Panhypogammaglobulinemia (HP:0003139) | 2.19154790 |
105 | Severe visual impairment (HP:0001141) | 2.18764721 |
106 | Abnormality of the intrinsic pathway (HP:0010989) | 2.17676757 |
107 | Generalized hyperpigmentation (HP:0007440) | 2.17299059 |
108 | Fat malabsorption (HP:0002630) | 2.17191832 |
109 | Abnormality of the fingertips (HP:0001211) | 2.14279867 |
110 | Abnormality of pyrimidine metabolism (HP:0004353) | 2.12837666 |
111 | Abnormality of T cell physiology (HP:0011840) | 2.12729904 |
112 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 2.12557397 |
113 | Autoimmune hemolytic anemia (HP:0001890) | 2.10829312 |
114 | Granulocytopenia (HP:0001913) | 2.10598892 |
115 | Lower limb hyperreflexia (HP:0002395) | 2.08027879 |
116 | Purpura (HP:0000979) | 2.07954573 |
117 | Hemoptysis (HP:0002105) | 2.07362995 |
118 | Renal tubular acidosis (HP:0001947) | 2.06412485 |
119 | Neoplasm of the liver (HP:0002896) | 2.04731969 |
120 | Pathologic fracture (HP:0002756) | 2.04403774 |
121 | Abnormality of sodium homeostasis (HP:0010931) | 2.04314168 |
122 | Epistaxis (HP:0000421) | 2.02250343 |
123 | Abnormality of methionine metabolism (HP:0010901) | 2.01215268 |
124 | Poikilocytosis (HP:0004447) | 12.6987934 |
125 | * Abnormality of the heme biosynthetic pathway (HP:0010472) | 10.0205051 |
126 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 1.98046584 |
127 | Albinism (HP:0001022) | 1.97935749 |
128 | Autoimmune thrombocytopenia (HP:0001973) | 1.97725006 |
129 | Thrombophlebitis (HP:0004418) | 1.97002724 |
130 | Pulmonary embolism (HP:0002204) | 1.95635561 |
131 | Onycholysis (HP:0001806) | 1.95628928 |
132 | Prolonged bleeding time (HP:0003010) | 1.95319331 |
133 | Spontaneous abortion (HP:0005268) | 1.94743882 |
134 | Increased mean platelet volume (HP:0011877) | 1.93647792 |
135 | Dysautonomia (HP:0002459) | 1.93172488 |
136 | Hyperglycinemia (HP:0002154) | 1.92665586 |
137 | Systemic lupus erythematosus (HP:0002725) | 1.91664896 |
138 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 1.91203971 |
139 | Colitis (HP:0002583) | 1.90546397 |
140 | Petechiae (HP:0000967) | 1.90385820 |
141 | Difficulty running (HP:0009046) | 1.89242915 |
142 | Abnormality of fatty-acid metabolism (HP:0004359) | 1.88884237 |
143 | Pustule (HP:0200039) | 1.88588221 |
144 | Recurrent gram-negative bacterial infections (HP:0005420) | 1.87501873 |
145 | Abnormality of serine family amino acid metabolism (HP:0010894) | 1.85904584 |
146 | Abnormality of glycine metabolism (HP:0010895) | 1.85904584 |
147 | Hypercholesterolemia (HP:0003124) | 1.85801590 |
148 | Nasal polyposis (HP:0100582) | 1.85579115 |
149 | * Hypochromic microcytic anemia (HP:0004840) | 1.82973315 |
150 | Acne (HP:0001061) | 1.82023896 |
151 | Pancreatic islet-cell hyperplasia (HP:0004510) | 1.81947658 |
152 | Abnormal platelet volume (HP:0011876) | 1.81765669 |
153 | Sepsis (HP:0100806) | 1.80476474 |
154 | Lymphopenia (HP:0001888) | 1.80419248 |
155 | Splenomegaly (HP:0001744) | 1.80399292 |
156 | Gingival bleeding (HP:0000225) | 1.79245391 |
157 | Orthostatic hypotension (HP:0001278) | 1.78395844 |
158 | Menorrhagia (HP:0000132) | 1.78362914 |
159 | Cortical dysplasia (HP:0002539) | 1.77776704 |
160 | Vomiting (HP:0002013) | 1.76955480 |
161 | Hyperglycinuria (HP:0003108) | 1.74330916 |
162 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 1.71761813 |
163 | Abnormality of nucleobase metabolism (HP:0010932) | 1.71373661 |
164 | Back pain (HP:0003418) | 1.71369525 |
165 | Delusions (HP:0000746) | 1.71077741 |
166 | Myocardial infarction (HP:0001658) | 1.68293722 |
167 | Spastic diplegia (HP:0001264) | 1.63309796 |
168 | Steatorrhea (HP:0002570) | 1.62071960 |
169 | Abnormal number of erythroid precursors (HP:0012131) | 1.61778489 |
170 | Sensorimotor neuropathy (HP:0007141) | 1.59720240 |
171 | Hypertensive crisis (HP:0100735) | 1.58902907 |
172 | Abnormal platelet function (HP:0011869) | 1.57213076 |
Rank | Gene Set | Z-score |
---|---|---|
1 | EIF2AK1 | 7.37449024 |
2 | TLK1 | 4.32053443 |
3 | RIPK4 | 3.85929211 |
4 | STK4 | 3.48560130 |
5 | ZAK | 2.65000945 |
6 | CDK12 | 2.59691272 |
7 | IRAK4 | 2.58503090 |
8 | BRSK1 | 2.55894913 |
9 | BLK | 2.38704765 |
10 | FGR | 2.27172409 |
11 | CDC7 | 2.26919909 |
12 | STK10 | 2.17775248 |
13 | BCKDK | 2.13886103 |
14 | MAPK11 | 2.07700302 |
15 | PRPF4B | 2.06091160 |
16 | TRIB3 | 1.99904008 |
17 | FES | 1.91848747 |
18 | TNK2 | 1.89886580 |
19 | CSK | 1.85506016 |
20 | PIM1 | 1.83284656 |
21 | GRK6 | 1.81156355 |
22 | TGFBR2 | 1.78019813 |
23 | PKN2 | 1.65732318 |
24 | MAP3K1 | 1.63687869 |
25 | HCK | 1.60175299 |
26 | EEF2K | 1.52662675 |
27 | ZAP70 | 1.51117149 |
28 | DYRK3 | 1.49699609 |
29 | BTK | 1.44312475 |
30 | CLK1 | 1.41706188 |
31 | TRPM7 | 1.41393649 |
32 | ERN1 | 1.38504856 |
33 | EPHB1 | 1.35811985 |
34 | CDK6 | 1.34513202 |
35 | MAP3K8 | 1.33324610 |
36 | VRK1 | 1.32828175 |
37 | GRK5 | 1.31166965 |
38 | NEK2 | 1.30782228 |
39 | ERBB2 | 1.30484780 |
40 | MAP3K10 | 1.29340669 |
41 | KSR2 | 1.28092339 |
42 | TAOK3 | 1.27043857 |
43 | RPS6KA5 | 1.21927530 |
44 | JAK2 | 1.21610795 |
45 | BUB1 | 1.20299994 |
46 | NEK1 | 1.18548866 |
47 | MAPKAPK3 | 1.16671260 |
48 | TIE1 | 1.16668456 |
49 | JAK3 | 1.16447153 |
50 | AURKB | 1.15658190 |
51 | FGFR4 | 1.14090349 |
52 | CDK4 | 1.13668786 |
53 | PTK6 | 1.12471331 |
54 | PRKAA1 | 1.09564667 |
55 | AURKA | 1.09051141 |
56 | MAP2K3 | 1.08579971 |
57 | ABL2 | 1.06460884 |
58 | TXK | 1.06452610 |
59 | BRSK2 | 1.06086451 |
60 | MAP3K11 | 1.04273199 |
61 | MELK | 1.04052328 |
62 | PBK | 1.01580706 |
63 | NME2 | 1.01427529 |
64 | MAP3K5 | 1.00676596 |
65 | MARK2 | 0.98363611 |
66 | CAMK1D | 0.95880892 |
67 | DAPK2 | 0.92253284 |
68 | TYK2 | 0.91817321 |
69 | GRK7 | 0.91523655 |
70 | SYK | 0.90369351 |
71 | HIPK2 | 0.89567969 |
72 | SIK1 | 0.88894274 |
73 | STK11 | 0.87216110 |
74 | KSR1 | 0.85619748 |
75 | SCYL2 | 0.84332730 |
76 | CDK19 | 0.83441897 |
77 | YES1 | 0.82753364 |
78 | FLT3 | 0.81643189 |
79 | CDC42BPA | 0.80844301 |
80 | SGK3 | 0.80747866 |
81 | MAP2K4 | 0.80668629 |
82 | CDK9 | 0.79529716 |
83 | PRKD2 | 0.78465058 |
84 | LCK | 0.78025534 |
85 | PRKAA2 | 0.76337697 |
86 | MAP3K2 | 0.74980454 |
87 | STK3 | 0.73502529 |
88 | TEC | 0.72876677 |
89 | CHEK2 | 0.72503049 |
90 | TTK | 0.68521617 |
91 | STK38 | 0.68051575 |
92 | BMX | 0.68029934 |
93 | ITK | 0.67741060 |
94 | WNK1 | 0.67405062 |
95 | ICK | 0.67288880 |
96 | SIK3 | 0.67121803 |
97 | TAOK1 | 0.65900991 |
98 | DYRK1B | 0.65352387 |
99 | IKBKB | 0.64777676 |
100 | IKBKE | 0.64050981 |
101 | MAP3K6 | 0.63557808 |
102 | MAP2K1 | 0.63107580 |
103 | PTK2B | 0.59904467 |
104 | NEK9 | 0.59619327 |
105 | PRKACG | 0.58611941 |
106 | SGK2 | 0.58158925 |
107 | MAP3K7 | 0.57575062 |
108 | PDPK1 | 0.56873881 |
109 | MAP3K14 | 0.55928450 |
110 | IRAK2 | 0.55421741 |
111 | PLK1 | 0.54687809 |
112 | KDR | 0.53466519 |
113 | MAP3K3 | 0.53377525 |
114 | BMPR2 | 0.52976252 |
115 | IRAK1 | 0.52380556 |
116 | CHEK1 | 0.51048873 |
117 | PINK1 | 0.50095796 |
118 | SIK2 | 0.49768040 |
119 | STK24 | 0.49545867 |
120 | RPS6KC1 | 0.49163570 |
121 | RPS6KL1 | 0.49163570 |
122 | SGK494 | 0.48882867 |
123 | SGK223 | 0.48882867 |
124 | RAF1 | 0.48431334 |
125 | PKN1 | 0.48021250 |
126 | MAPKAPK2 | 0.47929527 |
127 | FYN | 0.47889413 |
128 | ATM | 0.47067158 |
129 | SMG1 | 0.46509764 |
130 | MAPK12 | 0.46040587 |
131 | KIT | 0.45665867 |
132 | DAPK3 | 0.44384541 |
133 | JAK1 | 0.44329634 |
134 | MAP4K1 | 0.43740209 |
135 | MAP3K13 | 0.43533230 |
136 | MATK | 0.42628913 |
137 | RPS6KA6 | 0.41811333 |
138 | TBK1 | 0.41664274 |
139 | PIK3CG | 0.41642674 |
140 | BRD4 | 0.41469473 |
141 | LRRK2 | 0.41455000 |
142 | CSNK1D | 0.40766442 |
143 | CSF1R | 0.40524753 |
144 | EIF2AK2 | 0.40262554 |
145 | PLK3 | 0.39982539 |
146 | LYN | 0.39588579 |
147 | RPS6KB2 | 0.38788686 |
148 | MARK3 | 0.37325721 |
149 | SGK1 | 0.34083069 |
150 | TTN | 0.33728655 |
151 | PRKCQ | 0.33375739 |
152 | DYRK1A | 0.32303561 |
153 | MOS | 0.31920830 |
154 | PDK1 | 0.29799644 |
155 | MTOR | 0.28956600 |
156 | CAMK1G | 0.26842477 |
157 | EGFR | 0.25834469 |
158 | CDK1 | 0.24916600 |
159 | TAOK2 | 0.23352217 |
Rank | Gene Set | Z-score |
---|---|---|
1 | * Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 5.59013567 |
2 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 4.71109078 |
3 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 3.82320226 |
4 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 3.65537625 |
5 | Nitrogen metabolism_Homo sapiens_hsa00910 | 2.82967789 |
6 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 2.82136078 |
7 | Osteoclast differentiation_Homo sapiens_hsa04380 | 2.81565686 |
8 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 2.59853561 |
9 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.46481507 |
10 | Leishmaniasis_Homo sapiens_hsa05140 | 2.44654232 |
11 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 2.33541603 |
12 | * Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 2.33256150 |
13 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.30122320 |
14 | Arginine biosynthesis_Homo sapiens_hsa00220 | 2.27058758 |
15 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.22276361 |
16 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 2.22203691 |
17 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 2.20293506 |
18 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 2.11845166 |
19 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.99206581 |
20 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.95866570 |
21 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.92616178 |
22 | Tuberculosis_Homo sapiens_hsa05152 | 1.91251817 |
23 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.87385222 |
24 | ABC transporters_Homo sapiens_hsa02010 | 1.86211899 |
25 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.83427059 |
26 | Pancreatic cancer_Homo sapiens_hsa05212 | 1.81889004 |
27 | Primary immunodeficiency_Homo sapiens_hsa05340 | 1.76048983 |
28 | African trypanosomiasis_Homo sapiens_hsa05143 | 1.74374431 |
29 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 1.72049301 |
30 | Measles_Homo sapiens_hsa05162 | 1.71614437 |
31 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.65842175 |
32 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.61197073 |
33 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 1.60705926 |
34 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.59405532 |
35 | Alcoholism_Homo sapiens_hsa05034 | 1.57355882 |
36 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.56964046 |
37 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.54970030 |
38 | Sulfur relay system_Homo sapiens_hsa04122 | 1.52394398 |
39 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.49960034 |
40 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.49697268 |
41 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.49063373 |
42 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.48632972 |
43 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.48544879 |
44 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.46162213 |
45 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.42753262 |
46 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.42624119 |
47 | Peroxisome_Homo sapiens_hsa04146 | 1.41362598 |
48 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.38783799 |
49 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.36354485 |
50 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.36045170 |
51 | Influenza A_Homo sapiens_hsa05164 | 1.32224684 |
52 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.29577221 |
53 | Bile secretion_Homo sapiens_hsa04976 | 1.25889629 |
54 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.25523760 |
55 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.23851570 |
56 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.22295192 |
57 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.18401374 |
58 | One carbon pool by folate_Homo sapiens_hsa00670 | 1.17227223 |
59 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.17181069 |
60 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.16983210 |
61 | Histidine metabolism_Homo sapiens_hsa00340 | 1.16450021 |
62 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.16446589 |
63 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.15865252 |
64 | Hepatitis B_Homo sapiens_hsa05161 | 1.15757871 |
65 | Carbon metabolism_Homo sapiens_hsa01200 | 1.15274849 |
66 | Renal cell carcinoma_Homo sapiens_hsa05211 | 1.14930582 |
67 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.14585012 |
68 | VEGF signaling pathway_Homo sapiens_hsa04370 | 1.14430900 |
69 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.14334900 |
70 | Platelet activation_Homo sapiens_hsa04611 | 1.14230369 |
71 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.12856596 |
72 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.12385082 |
73 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.11459551 |
74 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.11030512 |
75 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.08280445 |
76 | Legionellosis_Homo sapiens_hsa05134 | 1.08019333 |
77 | Phagosome_Homo sapiens_hsa04145 | 1.07088569 |
78 | Glutathione metabolism_Homo sapiens_hsa00480 | 1.04836615 |
79 | Allograft rejection_Homo sapiens_hsa05330 | 1.04599905 |
80 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.03833424 |
81 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.03633642 |
82 | Endometrial cancer_Homo sapiens_hsa05213 | 1.02291538 |
83 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.00973318 |
84 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.98677021 |
85 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.98163292 |
86 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.96150928 |
87 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.92988196 |
88 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.92389533 |
89 | Lysine degradation_Homo sapiens_hsa00310 | 0.89489444 |
90 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.88222478 |
91 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.87274510 |
92 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.86310344 |
93 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.86176878 |
94 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.86174864 |
95 | Retinol metabolism_Homo sapiens_hsa00830 | 0.85912439 |
96 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.85475370 |
97 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.85219574 |
98 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.83739110 |
99 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.80806713 |
100 | Endocytosis_Homo sapiens_hsa04144 | 0.80760965 |
101 | Salmonella infection_Homo sapiens_hsa05132 | 0.80702945 |
102 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.80566346 |
103 | Shigellosis_Homo sapiens_hsa05131 | 0.79537925 |
104 | Malaria_Homo sapiens_hsa05144 | 0.77413380 |
105 | Cell cycle_Homo sapiens_hsa04110 | 0.76110053 |
106 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.75628525 |
107 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.75184375 |
108 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.75032946 |
109 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.74128671 |
110 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.73896692 |
111 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.73891909 |
112 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.72432594 |
113 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.71877074 |
114 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.70976450 |
115 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.70873660 |
116 | Thyroid cancer_Homo sapiens_hsa05216 | 0.70850650 |
117 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.70180876 |
118 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.69510453 |
119 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.67920097 |
120 | DNA replication_Homo sapiens_hsa03030 | 0.67154448 |
121 | Glioma_Homo sapiens_hsa05214 | 0.66399911 |
122 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.66105319 |
123 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.64843373 |
124 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.64106092 |
125 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.63504601 |
126 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.62432035 |
127 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.61509985 |
128 | Bladder cancer_Homo sapiens_hsa05219 | 0.61107344 |
129 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.60391596 |
130 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.59209230 |
131 | Colorectal cancer_Homo sapiens_hsa05210 | 0.58847739 |
132 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.58834385 |
133 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.55915322 |
134 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.55485123 |
135 | Prostate cancer_Homo sapiens_hsa05215 | 0.54016634 |
136 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.53835541 |
137 | HTLV-I infection_Homo sapiens_hsa05166 | 0.53668609 |
138 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.53285828 |
139 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.53125114 |
140 | Viral myocarditis_Homo sapiens_hsa05416 | 0.52026014 |
141 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.51274856 |
142 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.50925897 |
143 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.50795589 |
144 | Pertussis_Homo sapiens_hsa05133 | 0.50567520 |
145 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.49430877 |
146 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.46330184 |
147 | Other glycan degradation_Homo sapiens_hsa00511 | 0.45362152 |
148 | Long-term potentiation_Homo sapiens_hsa04720 | 0.43893485 |
149 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.42191420 |
150 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.42111900 |
151 | * Metabolic pathways_Homo sapiens_hsa01100 | 0.40029860 |
152 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.38985723 |
153 | Insulin resistance_Homo sapiens_hsa04931 | 0.38532454 |
154 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.33870387 |
155 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.23192556 |
156 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.22546177 |
157 | Prion diseases_Homo sapiens_hsa05020 | 0.21703195 |
158 | Apoptosis_Homo sapiens_hsa04210 | 0.17256171 |
159 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.16267454 |
160 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.15435615 |
161 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.14923313 |
162 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.14700335 |
163 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.13084952 |
164 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 0.12844939 |
165 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.12177193 |
166 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.11237296 |
167 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.11081685 |
168 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.10634027 |
169 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.09434030 |
170 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.09342482 |
171 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.08210816 |
172 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.06398393 |
173 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.05858365 |
174 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 0.04986310 |
175 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.04805561 |
176 | Hepatitis C_Homo sapiens_hsa05160 | 0.02120560 |